A top-5 pharmaceutical company sought the perspectives of payers in the US and major EU markets to ensure that the value of an innovative vaccine would ultimately be recognized by health systems.
Product Strategy
Accelerating R&D Efforts Through Patient Data Repository Partnerships
A multinational pharmaceutical company sought support in developing a strategy to partner with public/academic cancer patient data repositories to advance its own R&D programs.
Assessing a Therapy’s Potential Use and Adoption in Treatment Resistant Depression
To support a mid-stage clinical development program, a top-5 pharmaceutical company engaged Shift Health to obtain an understanding of physicians’ decision-making process with alternative therapies.
Advancing a Pharmaceutical-Grade Cannabis Portfolio Positioned to Address Health Needs
A player in the medical cannabis space required support to uncover and catalogue scientific evidence that established the link between specific cannabis-based metabolites and their therapeutic benefit.
Measuring Prescription Influence in the Complex Psychiatry Environment
Recognizing the dynamic nature of the psychiatry therapeutic arena, a top-5 pharmaceutical company required support in characterizing and prioritizing the stakeholder environment to inform how Medical Affairs could work with other functions to optimize patient care.
Mitigating Risks Associated with a Multinational Phase 3 Vaccine Clinical Trial
A leading pharmaceutical company required support in identifying and planning for risks and scenarios that could arise during a multinational Phase 3 vaccine clinical trial.